M&A Deal Summary |
|
|---|---|
| Date | 2014-11-03 |
| Target | Dihon Pharmaceutical Group Co. |
| Sector | Healthcare Services |
| Buyer(s) | Bayer |
| Deal Type | Add-on Acquisition |
| Deal Value | 460M EUR |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1863 |
| Sector | Life Science |
| Employees | 89,556 |
| Revenue | 46.6B EUR (2024) |
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 20 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 8 of 17 |
| Country: China M&A | 1 of 1 |
| Year: 2014 M&A | 3 of 3 |
| Size (of disclosed) | 7 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-01 |
Granar SA
Encarnacion, Paraguay Granar SA specializes in the breeding, production and marketing especially of improved soybean seeds adapted to the growing conditions that prevail in subtropical regions. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-06-10 |
Bayer AG - Bayer Diabetes-Care Unit
Leverkusen, Germany
|
Sell | $1.1B |
